The Danish Region Midt Schizophrenia (RMS) Cohort: Representative Cohort of Patients With a First-episode Schizophrenia Spectrum Disorder With Long-term Follow-up

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The objective of this study is to recruit patients at the first diagnosis with a schizophrenia spectrum disorder (SSD) and ultra-high risk patients (UHR), defined as patients with drug abuse and psychotic symptoms indicating a risk for developing schizophrenia. Thereby, the investigators aim to establish a large representative cohort of patients with a first-episode SSD or patients at UHR, enabling investigations of the etiology and long-term prognosis of SSDs. The primary aim is to learn more about the importance of adverse childhood experiences (ACEs) and the immune system in the etiology and course of schizophrenia. Patients will be followed with planned visits after 1, 2, 3, 12 and 24 months including online questionnaires after 2, 6, 10 and 26 weeks. There will be the possibility to contact patients again for subsequent follow-up visits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:

• Age ≥15 years

• Diagnosed within the previous 3 months with first-episode SSD (ICD-10: F20-29) or UHR (ICD-10: F1X.5)

• Able to give informed oral and written consent.

Locations
Other Locations
Denmark
Aarhus University Hospital Psychiatry
RECRUITING
Aarhus
Psychiatric Hospital Gødstrup
RECRUITING
Herning
Psychiatric Hospital Horsens
RECRUITING
Horsens
Psychiatric Hospital Randers
RECRUITING
Randers
Psychiatric Hospital Midt
RECRUITING
Silkeborg
Contact Information
Primary
Ole Köhler-Forsberg, MD, PhD
karkoe@rm.dk
0045 78471610
Time Frame
Start Date: 2024-02-20
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 350
Treatments
Schizophrenia
Patients with a SSD (ICD-10: F20-29) aged ≥15 years.
Ultra High Risk
Patients at UHR (ICD: 1\*.5) aged ≥15 years.
Related Therapeutic Areas
Sponsors
Leads: University of Aarhus
Collaborators: Aarhus University Hospital

This content was sourced from clinicaltrials.gov